Cargando…
Successful Treatment of Type B Insulin Resistance With Rituximab
CONTEXT: Type B insulin resistance is a very rare disease caused by autoantibodies against the insulin receptor. The mortality of type B insulin resistance is high (>50%), and management of this disease is not yet standardized. We report the successful treatment of a patient with type B insulin r...
Autores principales: | Manikas, Emmanouil-Dimitrios, Isaac, Iona, Semple, Robert K., Malek, Rana, Führer, Dagmar, Moeller, Lars C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422897/ https://www.ncbi.nlm.nih.gov/pubmed/25675382 http://dx.doi.org/10.1210/jc.2014-3552 |
Ejemplares similares
-
Update on Insulin Therapy for Type 2 Diabetes
por: Donner, Thomas, et al.
Publicado: (2012) -
Insulin Infusion Set Use: European Perspectives and Recommendations
por: Deiss, Dorothee, et al.
Publicado: (2016) -
Successful remission of type B insulin resistance syndrome without rituximab in an elderly male
por: Concepción-Zavaleta, Marcio José, et al.
Publicado: (2020) -
Gene drive for population genetic control: non-functional resistance and parental effects
por: Beaghton, Andrea K., et al.
Publicado: (2019) -
Why is phishing still successful?
por: Bhardwaj, Akashdeep, et al.
Publicado: (2020)